Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Randomized, Double Blind, Placebo Controlled, Dose Ranging, Parallel Group, Phase 2 Study of INCB028050 Compared to Background Therapy in Patients with Active Rheumatoid Arthritis with Inadequate Response to Any Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy including Biologics https://www.kusajili.com:443/Trial/KR-wrSJQIkKM-RNOGf2CzA%24a-randomized-double-blind-placebo-controlled-dose-ranging-parallel-group-phase-2-study-of-incb028050-compared-to-background-the
I have read and accept the terms of use of the site and the Privacy Policy
Send your message